Joshua Fein

The BCL2 selective inhibitor venetoclax induces rapid onset apoptosis of CLL cells in patients via a TP53-independent mechanism

Mary Ann Anderson, Jing Deng, John F. Seymour et al. · Blood · 2016 · 323 citations · Full text

Idelalisib given front-line for treatment of chronic lymphocytic leukemia causes frequent immune-mediated hepatotoxicity

Benjamin L. Lampson, Siddha Kasar, Tiago R. Matos et al. · Blood · 2016 · 284 citations · Full text

Outcomes of allogeneic haematopoietic stem cell transplantation from HLA-matched and alternative donors: a European Society for Blood and Marrow Transplantation registry retrospective analysis

Roni Shouval, Joshua Fein, Myriam Labopin et al. · The Lancet Haematology · 2019 · 215 citations

Alternative Donors, Transplantation, Marrow Transplantation +7

The evolutionary landscape of chronic lymphocytic leukemia treated with ibrutinib targeted therapy

Dan A. Landau, Clare Sun, Daniel Rosebrock et al. · Nature Communications · 2017 · 173 citations · Full text

Adverse Cardiovascular and Pulmonary Events Associated With Chimeric Antigen Receptor T-Cell Therapy

Adam Goldman, Elad Maor, David Bomze et al. · Journal of the American College of Cardiology · 2021 · 140 citations · Full text

Clinical Immunology, Pulmonary Arterial Hypertension, Allergy +12